Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

EverTrend Asset launches macro managed futures fund

Thursday, July 07, 2011
Opalesque Industry Update – EverTrend Asset has announced the launch of macro managed futures fund everTrend Global which is designed to provide investors with global exposure to a broad range of asset classes.

Robert Robbins, President and Portfolio Manager of everTrend Global commented: “I’m pleased to be able to offer this investment opportunity to investors in this environment of uncertainty. This fund was designed to offer diversification, flexibility, systematic risk management, and global exposure not available in mainstream investment products.”

Robbins explained that everTrend Global is a trend following fund, dedicated to investing in the direction of medium and longer term trends in a diversified group of futures markets. “Since change is the driver of both risk and returns, our funds are designed to profit from a wide variety of environments. Our systematic, trend following approach provides clients with a disciplined and flexible way to profit from macro cycles,” he added.

The executive boasted that everTrend is capable of providing results that are quantifiable and “ sustainable. Its diversified strategy has been tested “through myriad economic environments,” resulting to a “ robust fund that is capable of adapting to different market conditions and can reposition itself as it changes.”

“Diversification across seven distinct asset classes ensures that the fund remains balanced and positioned broadly, so that we capture returns and large trends wherever they may occur. Sophisticated risk-adjusted position sizing and portfolio risk controls underpin the everTrend portfolio management process. Our exposure to major currency and bond markets around the globe also provides investors with an embedded currency hedge,” Robbins explained.

He said that one of the key benefits of managed futures funds is that they can move opposite traditional stock/bond portfolios during bear markets. During testing, the fund provided its best returns during periods in which the equity markets posted large declines.
Komfie Manalo

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for